Amarin (AMRN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Amarin (AMRN) is Neutral.

The composite score behind that read is -0.01, weighing +0.09 of bullish evidence against -0.19 bearish.

Amarin last closed at $12.03, +0.33% on the session.

Against the IVW growth benchmark the position is -0.47% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

17 graded predictions for AMRN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Amarin in the 34th percentile on return on equity, where 100 is best.

Amarin is classified under Health Care / Biotechnology, with a market capitalisation of $253.26M.

StockMap tracks Amarin as the 228th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Amarin ranks 104th of 381 in the group, against a group median of -0.08.